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Objective: Multiple Sclerosis (MS) is a demyelinating autoimmune disease that imposes
a significant emotional burden with heavy psychosocial consequences. Several studies
have investigated the association between MS and mental disorders such as depression
and anxiety, and recently researchers have focused also on Post-traumatic Stress
Disorder (PTSD). This is the first study that investigates the usefulness of proposing
a treatment for PTSD to patients with MS.
Methods: A randomized controlled trial with patients with MS diagnosed with PTSD
comparing Eye Movement Desensitization and Reprocessing (EMDR; n = 20) and
Relaxation Therapy (RT; n = 22). The primary outcome measure was the proportion
of participants that no longer meet PTSD diagnosis as measured with Clinician
Administered PTSD Scale 6-months after the treatment.
Results: The majority of patients were able to overcome their PTSD diagnosis after only
10 therapy sessions. EMDR treatment appears to be more effective than RT in reducing
the proportion of patients with MS suffering from PTSD. Both treatments are effective in
reducing PTSD severity, anxiety and depression symptoms, and to improve Quality of
Life.
Conclusion: Although our results can only be considered preliminary, this study
suggests that it is essential that PTSD symptoms are detected and that brief and cost-
effective interventions to reduce PTSD and associated psychological symptoms are
offered to patients, in order to help them to reduce the psychological burden associated
with their neurological condition.
Trial registration: NCT01743664, https://clinicaltrials.gov/ct2/show/NCT01743664
Keywords: multiple sclerosis, PTSD, EMDR, relaxation therapy, stress
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INTRODUCTION
Multiple Sclerosis (MS) is a demyelinating autoimmune disease
of the central nervous system that affects both the brain and the
spinal cord by destroying the myelin sheath that protects the
nerve fibers, leaving plaques or scars on the damaged sites. MS
typically onsets during young age, and thus it poses a significant
emotional burden with heavy psychosocial consequences. The
disease substantially interferes with daily activities and family,
social and working life, disturbs emotional well-being, and
reduces Quality of Life (QoL) (Janssens et al., 2003).
Several studies have focused on the association between
MS and psychiatric illnesses, such as depression (Siegert and
Abernethy, 2005; Wallin et al., 2006; Beiske et al., 2008; Feinstein,
2011; Moore et al., 2012) and anxiety (Zorzon et al., 2001; José
Sá, 2008), but only recently have researchers focused on Post-
traumatic Stress Disorder (PTSD) associated to MS.
Relation between stress and MS relapses is complex and
reciprocal. An increasing amount of research (Mohr et al., 2004;
Mohr, 2007; Mitsonis et al., 2009) points toward an association
between stressful life events and relapse of MS, proposing that
stress may enhance the risk of exacerbation (Nisipeanu and
Korczyn, 1993; Brown et al., 2006). Moreover recent studies
focusing on psychoneuroimmunology are gaining importance,
proposing that stress may influence immune function via the
autonomic nervous system and the hypothalamus-pituitary
adrenal axis (Kern and Ziemssen, 2008; Karagkouni et al.,
2013).
Since chronic and potentially life-threatening illness was
explicitly included as a stressor that could precipitate PTSD
in DSM-IV (American Psychiatric Association, 1994), it was
therefore possible for individuals who suffer from MS to receive
a PTSD diagnosis related to their illness. From then on there
was a spread of empirical studies on Post-traumatic symptoms
in patients with different medical illnesses (Smith et al., 1999;
Kangas et al., 2002; Tedstone and Tarrier, 2003; Einsle et al.,
2012). As pointed out by some studies (Tedstone and Tarrier,
2003; Jackson et al., 2007), despite the fact that experience of a
serious medical illness can be undoubtedly stressful, some aspects
of this experience differ from what is traditionally defined and
widely studied as a trauma, such as serious car accidents, sexual
assaults, earthquakes or exposures to combat. At the same time
stressful experiences such as the communication of the diagnosis,
the information provided on the prognosis, some debilitating
treatments or disabling symptoms seem to be potential traumatic
events such as those already considered in the PTSD literature
(Tedstone and Tarrier, 2003). The existential threat due to a
life-threatening illness may be more comparable to long-term
trauma, such as that experienced in abusive relationships. As
in those cases, the traumatic experience that promotes PTSD
does not derive from a single event (Tedstone and Tarrier,
2003; Chalfant et al., 2004), but from the cumulative effect of
these negative experiences (Turner and Lloyd, 1995; Alonzo,
2000).
To date, only three studies have evaluated the prevalence and
the characteristics of PTSD secondary to MS (Chalfant et al.,
2004; Counsell et al., 2013; Ostacoli et al., 2013). All these studies
included different clinical types of MS (Relapsing-Remitting,
Primary Progressive and Secondary Progressive). The first study
evaluated a small sample of MS patients and found a relatively
high prevalence of PTSD (n = 9/58, i.e., 15.5%), similar
to that found in studies on cancer patients (Andrykowski
and Cordova, 1998; Jacobsen et al., 1998). Counsell et al.
(2013) conducted an Internet survey and found that almost
55.1% of their sample indicated that having MS was at
least somewhat traumatic. Ostacoli et al. (2013) found a
significant lower prevalence (12/232; 5.2%) than previous
studies, probably due to different tools being used for PTSD
diagnosis.
Moreover, none of these studies found an association between
PTSD and clinical indices of MS, such as duration, severity,
clinical type of MS and degree of disability, confirming that PTSD
is more related to individual factors than to the precipitating
event (Brewin et al., 2000).
Several studies have highlight that PTSD, if not treated, is
long-lasting (Van Etten and Taylor, 1998; Andrykowski et al.,
2000; Peris et al., 2011) and it may be a highly debilitating and
impairing condition with also huge societal costs (Kessler, 2000;
Galatzer-Levy et al., 2013; Tuerk et al., 2013).
Although there is extensive evidence on the effectiveness of
treatments for PTSD, to date no study has been conducted
to investigate the usefulness of proposing a treatment for
this disorder to patients with MS. Effective treatments for
PTSD include individual Trauma Focused CBT (TF-CBT),
Eye Movement Desensitization and Reprocessing (EMDR), and
stress management/relaxation training (Silver et al., 1995; Taylor
et al., 2003; Bisson and Andrew, 2007; Tol et al., 2013), but
clinical guidelines indicate that trauma-focused therapies, such as
EMDR and TF-CBT are more effective than non trauma-focused
intervention (National Collaborating Centre for Mental Health
(UK), 2005).
Both EMDR and Relaxation Therapy (RT) were effectively
used with patients suffering from other medical diseases such
as chronic pain (Grant and Threlfo, 2002; Schneider et al.,
2008; Chang et al., 2015), fibromyalgia (Friedberg, 2004;
Theadom et al., 2015), myocardial infarction (Arabia et al., 2011;
Whalley et al., 2014) and cancer (Yoo et al., 2005; Capezzani et al.,
2013).
The main purpose of this study was to investigate the efficacy
of EMDR in treating MS-related PTSD as compared to RT, in
order to prove the role of EMDR as an elective intervention also
in this specific population. Furthermore, as a secondary aim, we
evaluated the efficacy of EMDR and RT on Post-traumatic Stress-
associated symptoms (i.e., anxiety and depression), and on QoL
and fatigue.
Lastly, we aimed to detect possible differences between these
two treatments (EMDR vs. RT) at the follow-up evaluation for
Post-traumatic Stress-associated symptoms and QoL.
MATERIALS AND METHODS
This was a randomized controlled clinical trial where two active
treatments (EMDR and RT) were compared with a restricted
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randomization in a 1:1 ratio, conducted in Italy. The trial
registration number is NCT01743664.
Participants
Patients with MS were consecutively recruited from 2010 to
2013 from the Regional Reference Centre for Multiple Sclerosis
(CReSM) affiliated with the University Hospital San Luigi
Gonzaga of Orbassano, Turin, Italy. This study was approved
by the Research Ethics Committee of the University Hospital
San Luigi Gonzaga. Informed consent was obtained from all the
participants.
Inclusion criteria were as follows: (1) definite diagnosis of
a relapsing-remitting and primary or secondary progressive
MS disease (McDonald Criteria) (Polman et al., 2011); (2) age
between 18 and 65 years; (3) clinically inactive phase of the
disease; (4) fluent Italian speaker; (5) legal capacity to consent
to the treatment; (6) diagnosis of PTSD; (7) Post-traumatic
symptoms present for at least 3 months; (8) willingness to
suspend all concomitant psychological treatment; (9) suspension
of all psychotropic medications at least 1 month before the
treatment or maintenance at baseline level throughout the
study.
Exclusion criteria were as follows: (1) presence of severe
psychiatric disorders such as psychosis or bipolar disorder; (2)
presence of severe medical conditions other than MS, such as
diabetes, strokes or traumatic brain injuries; (3) drug or alcohol
abuse; (4) suicide attempts; (5) overt dementia; (6) corticosteroid
treatment during the previous 30 days.
Recruitment and Measures
Participants were recruited with a two-step screening: the
Impact of Event Scale-Revised (IES-R) was administered to
all patients corresponding to the neurological inclusion and
exclusion criteria, specifying in the instructions that they consider
only the illness as the traumatic event. The IES-R (Horowitz
et al., 1979; Weiss and Marmar, 1997) is a 22- item self-
report questionnaire consisting of three subscales (eight items
relate to intrusions, eight items evaluate avoidance, and six
items assess hyperarousal). The scale assesses subjective distress
caused by traumatic events. A cut-off equal to or above 33,
which is the cut-off most widely recognized in the literature
(Creamer et al., 2003), is considered indicative of Post-traumatic
stress symptoms.
Patients with scores equal to or above the cut-off of 33 were
assessed with the PTSD module of Structured Clinical Interview
for DSM-IV (SCID) (First, 1997) in order to confirm diagnosis
of PTSD. Only PTSD primarily related to MS was considered.
We also assessed the presence of previous trauma other than that
related to MS, but they were not relevant to diagnose PTSD in
this study.
Then patients with a confirmed diagnosis of PTSD were
assessed with the Clinician-Administered PTSD Scale (CAPS)
(Blake et al., 1995), a clinical semi-structured interview based
on the DSM-IV-TR with B (intrusion), C (avoidance), and D
(hyperarousal); to determine the presence of a symptom, we
utilized the rule “1,2”: a frequency score of 1 (scale 0 = “none
of the time” to 4 = “most or all of the time”) and an intensity
score of 2 (scale 0 = “none” to 4 = “extreme”) is required for
a particular symptom to meet criterion (Weathers et al., 2001).
A severity score is calculated by adding together the frequency
and intensity scores of subscales. Additional questions assess
Criteria A, E, and F. CAPS is considered the gold standard
in assessing PTSD (Foa and Tolin, 2000; Weathers et al.,
2001).
The following psychological questionnaires were also
administered:
- Hospital Anxiety and Depression Scale (HADS) was
developed to identify caseness (possible and probable) of
anxiety disorders and depression among patients in non-
psychiatric hospital clinics. It is divided into an Anxiety
subscale (HADS-A) and a Depression subscale (HADS-D)
(Zigmond and Snaith, 1983; Bjelland et al., 2002). Each
subscale contains seven items, which are evaluated by the
patient on a four-point Likert scale (0–3), so that the possible
scores range from 0 to 21 for both anxiety and depression.
For each subscale, a result of 0–7 represents the normal
condition; 8–10 identify mild cases; 11–15 moderate cases;
and 16 or above indicates the presence of severe cases
(Crawford et al., 2001; Quelhas and Costa, 2009). The tool
has also been validated for use with patients with MS
(Honarmand and Feinstein, 2009).
- Chicago Multiscale Depression Inventory (CMDI) is a 42-
item, self-report questionnaire which was developed to assess
depression in MS and other chronic diseases. The subscales
assess mood (dysphoria), vegetative symptoms (physical
malfunctioning) and evaluative symptoms (self-criticism).
The mood subscale alone provides a more conservative
indication of depression than total CMDI score (Solari et al.,
2004).
- Functional Assessment of QoL in MS (FAMS) is a factorially
derived self-report scale designed to assess six primary
aspects of QOL of patients with MS: Mobility, Symptoms,
Emotional Well-Being, General Contentment Thinking and
Fatigue, and Family/Social Well- Being (Cella et al., 1996;
Patti et al., 2007).
- Trauma Antecedent Questionnaire (TAQ) is a questionnaire
to assess the trauma load due to previous traumas. The
TAQ asks for the frequency (never, rarely, commonly)
of experiences assigned to 11 domains (ranging from
positive experiences such as competence and safety to
negative experiences such as neglect, physical, emotional,
sexual abuse, and witnessing trauma), separately assesses
four developmental periods including early childhood (0–
6), middle childhood, (7–12), adolescence (13–18), and
adulthood (19+) (Garieballa et al., 2006).
- Fatigue Severity Scale (FSS) is a nine item one-dimensional
questionnaire assessing the severity, frequency and impact of
fatigue on daily life (Krupp et al., 1989). The cut-off of 36 is
indicative of a severe fatigue (Flachenecker et al., 2002).
Lastly, patients received a score on the Expanded Disability
Status Scale (EDSS) (Kurtzke, 1983, 2015) from their neurologist,
to assess the level of disability.
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Assessment Points and Randomization
The psychological assessments were administered at pre-
intervention (T0), at post-intervention (T1) that was about 12–
15 weeks later, and at follow-up (T2) 6 months after the end of
the treatment. T2 was considered as the main assessment point
throughout all the analyses. Assessments were independent and
blind to treatment.
The research protocol was then proposed to patients
with PTSD who met the inclusion/exclusion criteria, with
an explanation of the aims of the study, its relevance for
MS patients and the possibility that they may be included,
by random assignment, in the treatment or control group
for the period of the study, with the same timing and
assessment tools. If they agreed, they signed the informed
consent and they were randomized to the experimental group
(EMDR) or to the control group (RT), using a block-wise
randomization sequence (block size of 10). The sequence
was determined by an independent statistical consultant
using the “Random Number Generators” function in SPSS
version 14.0.
Interventions
Treatments were independent and blinded to the clinical
psychologists conducting the clinical assessments. All the
participants, regardless of the type of treatment, received 10
individual 60-min-long treatment sessions conducted over 12–
15 weeks, preceded by two sessions for history taking with
particular attention to any stressful episodes in their life
histories.
Eye Movement Desensitization and Reprocessing treatment
was administered in accordance with Shapiro’s protocol for
traumatic events (Shapiro, 2001). In the first session the patient
is trained to stabilization techniques, such as the Safe Place.
These imaginary exercises are used as a coping strategy to
reduce distress, and the patient can also practice them at
home as homework, or wherever and whenever they are
needed. In the successive sessions the patient is induced to
recall the traumatic images related to the illness, focusing on
his/her worst negative thoughts, images or body sensations,
thus provoking emotional disturbance, while the therapist uses
external stimuli (usually eye movements, or tapping). Between
each set of stimulation the patient reports thoughts, feelings
or images that become the focus of the ongoing reprocessing.
The residual distress becomes the focus of the next session
of EMDR and the process continues until the distress evoked
by the traumatic events, both past and future-oriented, is
reduced, and negative cognitions are replaced by positive
ones.
The three clinicians in the EMDR condition had more
than 6 years’ experience in the liaison setting, working at the
Clinical Psychology and Psychosomatics Service, Mental Health
Department of the University Hospital San Luigi Gonzaga, with
Level II EMDR training and a minimum of 3 years of experience
in treating patients with PTSD. They received extensive training
and supervision in the manualized protocol established for the
study from a certified senior EMDR instructor.
Relaxation therapy included a series of relaxation techniques,
including diaphragmatic breathing, progressive muscle
relaxation, visualization, cue-controlled relaxation, and rapid
relaxation (van Kessel et al., 2008). Relaxation treatment was
performed by two psychotherapists working in the same facility
of the EMDR intervention. The two clinicians in the Relaxation
condition were at MSc level or higher, with a certified training
in relaxation techniques and they had a minimum of 3 years’
experience treating patients with PTSD.
Statistical Analysis
Data were processed and analyzed using IBM SPSS (Statistical
Package for Social Sciences) version 19.0.
Both parametric and non-parametric tests were used, in
accordance with Shapiro–Wilk as a test for normality. Baseline
group differences were assessed using Student’s t-test or Mann–
Whitney U test to compare the two groups for continuous
measures and Fisher’s Exact Test for categorical measures.
Fisher’s Exact Test was used to evaluate the association
between the treatment group (EMDR vs. RT) and the PTSD
diagnosis at T1 and at T2. Cramer’s V was used to calculate the
effect size for the primary outcome (proportion of participants
that no longer meet PTSD diagnosis as measured with CAPS
at T2).
GLM repeated measures multivariate ANOVA (RM-
MANOVA) was used to analyze the main pre- and
post-intervention effects and interactions both between and
within EMDR and RT groups. Pairwise comparison between
groups were made by simple contrast and are reported as means
difference with the Sidak correction 95% Confidence Interval
(95%CI) for multiple comparisons.
An intention to treat analysis was not possible due to patients’
refusal of following evaluations.
All tests were two-sided and a p < 0.05 was considered
statistically significant throughout all analyses.
RESULTS
Figure 1 shows the flow diagram with number of participants at
each assessment stage.
A total of 988 patients with MS were screened with the IES-
R; only 247 of these patients presented IES-R score above the
cut-off (25%). Fifty-two patients (5.3%) refused to continue the
evaluation (refusal rate: 21.1%). Of the other 195 patients, 66
meet the criteria of PTSD diagnosis (6.7%). Fourteen patients
refused to participate (the reasons were mainly the distance of the
place of residence from the place of treatment and the inability
to independently reach the place of treatment) and two patients
were excluded because they had a bipolar disorder.
Fifty patients were randomized: 25 were assigned to the EMDR
intervention and 25 were assigned to the RT intervention.
Five patients did not begin the treatment (four in the EMDR
group and one in the RT group) and three patients (one in the
EMDR group and two in the RT group) attended only the first two
sessions. These patients refused to continue with the assessment
at T1 and T2 and therefore it was not possible to include
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FIGURE 1 | Flow diagram of the progress through the phases of the research.
them in the statistical analysis. Therefore a total of 42 patients
(20 in the EMDR group and 22 in the RT group) completed
the treatment and were assessed at the post-intervention (T1
and T2).
Table 1 presents socio-demographic characteristics of these
patients at baseline. There were no significant differences in
demographics and in clinical characteristics between the two
groups at baseline (T0).
Firstly, we evaluated the proportion of patients that no longer
meet PTSD diagnostic criteria at the end of the treatment (T1)
and at follow-up assessment (T2). At T1 we found that 17 out of
20 patients in the EMDR group (85%) and 16 out of 22 patients
(72.7%) in the RT group did not meet PTSD diagnosis criteria
any longer. At T2, that is considered the primary outcome of our
study, we found that all the patients in the EMDR group (20 out of
20, 100%) and 17 out of 22 patients (77.3%) in the RT group did
not meet PTSD diagnosis criteria, with a statistically significant
difference (χ2 = 5.160, p = 0.049; Cramer’s V = 0.350) in favor
of EMDR.
Then we evaluated whether the different psychotherapy
treatments (EMDR or RT) had a different impact on the
psychological variables of interests. A Repeated-Measures
MANOVA was performed on the pre- (T0) and post-intervention
(T2) clinical scores (CAPS-Total, HADS-Anxiety, HADS-
Depression, IES-R, FSS, CMDI-Mood, FAMS-Total), comparing
group and time effects and interactions between group and time.
The RM-MANOVA yielded a significant pre-post main effect
[F(7,34) = 45.244, p < 0.001; η2p = 0.903], while no significant
interaction was found between the pre-post measures and the
treatment condition [F(7,34) = 0.631, p = 0.727; η2p = 0.115].
Significant time effects were found across both groups on all
variables, indicating that the mean participant scores improved
from time 0 (pre-intervention) to time 1 (T2) in both groups
without significant differences (Table 2).
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TABLE 1 | Demographic data of participants at baseline.
EMDR (N = 20)
Mean (SD)/Median (IQR)
RT (N = 22)
Mean (SD)/Median (IQR)
p
Age (years) 39.52 (11.68) 40.66 (10.03) 0.736a
Education (years) 12.00 (7) 13.00 (4) 0.524b
Years since MS diagnosis 7.00 (10.50) 7.00 (10.25) 0.743b
Previous traumas 3.5 (6) 5 (7) 0.646b
EDSS 2.00 (4.50) 2.00 (1.60) 0.324b
n (%) n (%)
Gender
Female
Male
15 (75)
5 (25)
19 (86.36)
3 (13.64)
0.445c
Employment status
Unemployed
Employed
Pensioned
Student
6 (30)
8 (40)
2 (10)
4 (20)
5 (22.73)
14 (63.64)
2 (9.09)
1 (4.54)
0.321c
Marital status
Single
Married
Separated/divorced
Widowed
Cohabitee
7 (35)
10 (50)
1 (5)
0 (0)
2 (10)
8 (36.36)
9 (40.91)
3 (13.65)
1 (4.54)
1 (4.54)
0.732c
MS disease status
Relapsing-remitting
Primary progressive
Secondary progressive
17 (85)
1 (5)
2 (10)
19 (86.36)
1 (4.54)
2 (9.1)
1.000c
EMDR, Eye Movement Desensitization and Reprocessing group; RT, Relaxation Therapy group. aPearson’s independent samples t-test. bMann–Whitney U test. cFisher’s
exact test.
TABLE 2 | Comparison of clinical variables between pre- (T0) and post-treatment (T2) for the two groups (EMDR and RT).
Pre-treatment Post-treatment p∗ η2p
RT (N = 22) EMDR (N = 20) RT (N = 22) EMDR (N = 20)
CAPS-Total 44.41 (11.13) 44.55 (14.19) 19.54 (15.66) 16.60 (10.11) <0.001 0.823
IES-R-Total 51.36 (9.58) 53.05 (12.87) 28.68 (19.39) 28.25 (18.28) <0.001 0.596
HADS-Anxiety 11.32 (3.76) 12.10 (3.95) 7.64 (5.19) 7.40 (3.93) <0.001 0.480
HADS-Depression 10.36 (4.09) 10.15 (3.38) 7.73 (4.73) 7.20 (3.93) <0.001 0.295
CMDI-Mood 37.36 (11.00) 37.25 (12.36) 31.50 (13.55) 27.05 (13.16) <0.001 0.280
FSS 43.95 (13.79) 43.10 (15.10) 39.18 (15.94) 37.60 (19.67) 0.029 0.114
FAMS-Total 96.73 (31.53) 88.80 (34.33) 109.82 (35.99) 102.75 (39.43) 0.001 0.232
Data are mean (SD). RT, Relaxation Therapy group; EMDR, Eye Movement Desensitization and Reprocessing group. ∗significant pre–post effect, independent of the type
of treatment (RT or EMDR).
DISCUSSION
The present study is the first that evaluates the efficacy of two
different types of psychological treatment for PTSD in patients
with MS.
The most significant result emerging from this study is that the
majority of patients were able to overcome their PTSD diagnosis
after only 10 therapy sessions.
As expected, EMDR treatment appears to be more effective
than RT in reducing the proportion of patients with MS suffering
from PTSD. This is in accordance with guidelines that indicate
that trauma-focused therapies, such as EMDR and TF-CBT, are
more effective than non-trauma focused intervention, also having
a more stable effect (National Collaborating Centre for Mental
Health (UK), 2005; Bisson and Andrew, 2007; Bisson et al.,
2013).
Both treatments were able to significantly reduce levels of
PTSD symptoms and PTSD severity, showing that a non-trauma
focused intervention such as RT could be as efficacious as EMDR
in this specific population. As this is the first study aiming to
investigate this important issue, it is possible that our sample
does not allow possible differences between the two treatments
to be revealed; future studies are needed to confirm these
results.
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Furthermore, both treatments are effective in reducing anxiety
and depression symptoms even in a limited number of sessions,
with an effect that lasts at least 6 months after the end of the
psychological treatment. Both treatments worked on emotional
stabilization and containment and maybe these components, that
are present in both EMDR and RT, are the effective elements
causing an improvement of anxiety and depression secondary
to MS.
In line with previous studies focusing on EMDR and RT
efficacy on QoL and fatigue related to other physical illness
such as cancer or fibromyalgia (Friedberg, 2004; Yoo et al.,
2005; Capezzani et al., 2013; Theadom et al., 2015), our
study also showed QoL and fatigue improving significantly
after both treatments. This result suggests that treatments that
focus on Post-traumatic symptoms could also be useful to
target lifestyle components, which are of great importance for
patients who have to deal with a chronic disabling disease such
as MS.
The results of this study could be interpreted also taking
into account the recent changes in DSM-5, which states that
medical disease per se can no longer be considered as a
stressor event to qualify for a criterion A for PTSD diagnosis
(American Psychiatric Association, 2013). DSM-5 also states
that Adjustment Disorders are common accompaniments of
medical illness and may be the major psychological response
to a medical disorder (American Psychiatric Association, 2013).
According to Kangas (2013), the stress reaction to a medical
disease can include not only symptoms closely associated
with PTSD but also a number of other symptoms that can
be better understood by other diagnostic categories such
as Adjustment Disorder. In fact, in this specific population
the traumatic components seem to be part of a more
complex adaptation process to the illness and the assessment
of stress response symptoms may be complicated by the
multiplicity and indeterminate nature of the stressor events
and by the confounding effect of symptoms related to the
illness or treatment (Kwakkenbos et al., 2014). Consistent
with Kangas (2013), the results of this study suggest that
EMDR could be a promising effective treatment also for
Adjustment Disorder with Post-traumatic symptoms, in addition
to PTSD.
Moreover, the majority of patients in our study reported
previous traumas (e.g., sexual abuse, physical and psychological
violence, complicated bereavement). This finding is in line
with the accumulated burden of adversity model (Alonzo,
2000), according to which MS-related traumatic experiences
(e.g., communication of the diagnosis, disabling treatments,
possible exacerbation and/or recurrence of disease, functional
impairment, fear of being confined to a wheelchair), when
added to previous adverse experiences in life, may act as a
trigger for developing PTSD or other trauma- and stressor-
related disorders. Future studies should keep in mind these
considerations and try to adapt already available treatments
to the complex psychological and medical condition of these
patients.
This study has also some strengths. It is the first ever study to
evaluate the efficacy of psychological interventions for PTSD and
associated symptoms in patients with MS.
The present study has some limitations. The number of
included patients treated with EMDR and RT is not large, despite
the very large group of patients screened. Another limitation
is that there was no placebo or waiting list group, in order to
control for the effect of time. This limit has an ethical implication,
taking into account that PTSD symptom resolution does not
occur with the passage of time, as shown in studies with cancer
patients (Gonçalves et al., 2011). Also, depression in MS is largely
chronic (Koch et al., 2015); therefore it’s extremely likely that
untreated PTSD related to MS would not improve without any
treatment.
Although our results can only be considered preliminary,
this study suggests that EMDR is more effective than RT in
reducing the proportion of patients with MS suffering from
PTSD. Both EMDR and RT are effective for reducing Post-
traumatic Stress symptoms and associated symptoms, also within
a limited number of sessions.
These encouraging results suggest that it is essential that
PTSD symptoms are detected and that brief and cost-effective
interventions to reduce PTSD and associated psychological
symptoms are offered to patients, in order to help them to reduce
the psychological burden associated with their neurological
condition.
AUTHOR CONTRIBUTIONS
LO, AZ, and AH were responsible for the conception and
the design of the study. SC, MB, GB, FO, MC, and SM were
responsible for data collection and analysis. SC wrote the article,
which was critically revised by MB, GB, FO, MC, AH, AZ, SM,
and LO. All authors read and approved the final version of the
manuscript.
FUNDING
This work was supported by FISM—Fondazione Italiana Sclerosi
Multipla [2009/R/11].
ACKNOWLEDGMENTS
We would like to thank the participants involved in the study
for their time and effort. We are very grateful to Debora
Boni, Massimo Castaldo, Luana Marnetto, Manuela Negro, and
Clarisse Zaccarino for their contribution to this study. We want
also to thank Roberto D’Amico for statistical suggestions.
Frontiers in Psychology | www.frontiersin.org 7 April 2016 | Volume 7 | Article 526
fpsyg-07-00526 April 19, 2016 Time: 15:50 # 8
Carletto et al. EMDR vs. Relaxation Therapy for PTSD in MS
REFERENCES
Alonzo, A. A. (2000). The experience of chronic illness and post-traumatic stress
disorder: the consequences ofcumulative adversity. Soc. Sci. Med. 198250,
1475–1484. doi: 10.1016/S0277-9536(99)00399-8
American Psychiatric Association (1994). Diagnostic and Statistical Manual of
Mental Disorders, 4th Edn. Washington DC: American Psychiatric Pub.
American Psychiatric Association (2013). Diagnostic and Statistical Manual of
Mental Disorders: DSM-5. Washington, DC: American Psychiatric Publishing,
Inc.
Andrykowski, M. A., and Cordova, M. J. (1998). Factors associated with
PTSD symptoms following treatment for breast cancer: test of the
andersen model. J. Trauma. Stress 11, 189–203. doi: 10.1023/A:10244907
18043
Andrykowski, M. A., Cordova, M. J., McGrath, P. C., Sloan, D. A., and Kenady,
D. E. (2000). Stability and change in posttraumatic stress disorder symptoms
following breast cancer treatment: a 1-year follow-up. Psychooncology 9,
69–78. doi: 10.1002/(SICI)1099-1611(200001/02)9:1<69::AID-PON439>3.3.
CO;2-I
Arabia, E., Manca, M. L., and Solomon, R. M. (2011). EMDR for survivors of life-
threatening cardiac events: results of a pilot study. J. EMDR Pract. Res. 5, 2–13.
doi: 10.1891/1933-3196.5.1.2
Beiske, A. G., Svensson, E., Sandanger, I., Czujko, B., Pedersen, E. D., Aarseth, J. H.,
et al. (2008). Depression and anxiety amongst multiple sclerosis patients. Eur. J.
Neurol. 15, 239–245. doi: 10.1111/j.1468-1331.2007.02041.x
Bisson, J., and Andrew, M. (2007). Psychological treatment of post-traumatic
stress disorder (PTSD). Cochrane Database Syst. Rev. 18:CD003388. doi:
10.1002/14651858.CD003388.pub3
Bisson, J., Roberts, N. P., Andrew, M., Cooper, R., and Lewis, C. (2013).
Psychological therapies for chronic post-traumatic stress disorder
(PTSD) in adults. Cochrane Database Syst. Rev. 12:CD003388. doi:
10.1002/14651858.CD003388.pub4
Bjelland, I., Dahl, A. A., Haug, T. T., and Neckelmann, D. (2002). The validity
of the hospital anxiety and depression scale. An updated literature review.
J. Psychosom. Res. 52, 69–77. doi: 10.1016/S0022-3999(01)00296-3
Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D.,
Charney, D. S., et al. (1995). The development of a clinician-administered PTSD
scale. J. Trauma. Stress 8, 75–90. doi: 10.1002/jts.2490080106
Brewin, C. R., Andrews, B., and Valentine, J. D. (2000). Meta-analysis of risk factors
for posttraumatic stress disorder in trauma-exposed adults. J. Consult. Clin.
Psychol. 68, 748–766. doi: 10.1037/0022-006X.68.5.748
Brown, R. F., Tennant, C. C., Sharrock, M., Hodgkinson, S., Dunn, S. M., and
Pollard, J. D. (2006). Relationship between stress and relapse in multiple
sclerosis: part II. Direct and indirect relationships. Mult. Scler. 12, 465–475. doi:
10.1191/1352458506ms1296oa
Capezzani, L., Ostacoli, L., Cavallo, M., Carletto, S., Fernandez, I., Solomon, R.,
et al. (2013). EMDR and CBT for cancer patients: comparative study of effects
on PTSD, anxiety, and depression. J. EMDR Pract. Res. 7, 134–143. doi:
10.1891/1933-3196.7.3.134
Cella, D. F., Dineen, K., Arnason, B., Reder, A., Webster, K. A., Karabatsos, G.,
et al. (1996). Validation of the functional assessment of multiple sclerosis
quality of life instrument. Neurology 47, 129–139. doi: 10.1212/WNL.47.
1.129
Chalfant, A. M., Bryant, R. A., and Fulcher, G. (2004). Posttraumatic stress disorder
following diagnosis of multiple sclerosis. J. Trauma. Stress 17, 423–428. doi:
10.1023/B:JOTS.0000048955.65891.4c
Chang, K.-L., Fillingim, R., Hurley, R. W., and Schmidt, S. (2015). Chronic pain
management: nonpharmacological therapies for chronic pain. FP Essent. 432,
21–26.
Counsell, A., Hadjistavropoulos, H. D., Kehler, M. D., and Asmundson,
G. J. G. (2013). Posttraumatic stress disorder symptoms in individuals with
multiple sclerosis. Psychol. Trauma Theor. Res. Pract. Policy 5, 448–452. doi:
10.1037/a0029338
Crawford, J. R., Henry, J. D., Crombie, C., and Taylor, E. P. (2001). Normative data
for the HADS from a large non-clinical sample. Br. J. Clin. Psychol. Br. Psychol.
Soc. 40, 429–434. doi: 10.1348/014466501163904
Creamer, M., Bell, R., and Failla, S. (2003). Psychometric properties of the
impact of event scale—revised. Behav. Res. Ther. 41, 1489–1496. doi:
10.1016/j.brat.2003.07.010
Einsle, F., Kraft, D., and Köllner, V. (2012). Post-traumatic stress disorder
(PTSD) in cardiology and oncology–which diagnostic tools should be used?
J. Psychosom. Res. 72, 434–438. doi: 10.1016/j.jpsychores.2012.02.008
Feinstein, A. (2011). Multiple sclerosis and depression. Mult. Scler. 17, 1276–1281.
doi: 10.1177/1352458511417835
First, M. B. (1997). User’s Guide for the Structured Clinical Interview for DSM-
IV axis I Disorders SCID-I: Clinician Version. Washington, DC: American
Psychiatric Press.
Flachenecker, P., Kümpfel, T., Kallmann, B., Gottschalk, M., Grauer, O.,
Rieckmann, P., et al. (2002). Fatigue in multiple sclerosis: a comparison of
different rating scales and correlation to clinical parameters. Mult. Scler. 8,
523–526. doi: 10.1191/1352458502ms839oa
Foa, E. B., and Tolin, D. F. (2000). Comparison of the PTSD symptom scale-
interview version and the clinician-administered PTSD scale. J. Trauma. Stress
13, 181–191. doi: 10.1023/A:1007781909213
Friedberg, F. (2004). Eye movement desensitization in fibromyalgia:
apilot study. Complement. Ther. Nurs. Midwifery 10, 245–249. doi:
10.1016/j.ctnm.2004.06.006
Galatzer-Levy, I. R., Ankri, Y., Freedman, S., Israeli-Shalev, Y., Roitman, P.,
Gilad, M., et al. (2013). Early PTSD symptom trajectories: persistence,
recovery, and response to treatment: results from the jerusalem trauma
outreach and prevention study (J-TOPS). PLoS ONE 8:e70084. doi:
10.1371/journal.pone.0070084
Garieballa, S. S., Schauer, M., Neuner, F., Saleptsi, E., Kluttig, T., Elbert, T.,
et al. (2006). Traumatic events, PTSD, and psychiatric comorbidity in forensic
patients–assessed by questionnaires and diagnostic interview. Clin. Pract.
Epidemiol. Ment. Health 2:7. doi: 10.1186/1745-0179-2-7
Gonçalves, V., Jayson, G., and Tarrier, N. (2011). A longitudinal investigation of
posttraumatic stress disorder in patients with ovarian cancer. J. Psychosom. Res.
70, 422–431. doi: 10.1016/j.jpsychores.2010.09.017
Grant, M., and Threlfo, C. (2002). EMDR in the treatment of chronic pain. J. Clin.
Psychol. 58, 1505–1520. doi: 10.1002/jclp.10101
Honarmand, K., and Feinstein, A. (2009). Validation of the hospital anxiety
and depression scale for use with multiple sclerosis patients. Mult. Scler. 15,
1518–1524. doi: 10.1177/1352458509347150
Horowitz, M., Wilner, N., and Alvarez, W. (1979). Impact of event scale: a measure
of subjective stress. Psychosom. Med. 41, 209–218. doi: 10.1097/00006842-
197905000-00004
Jackson, J. C., Hart, R. P., Gordon, S. M., Hopkins, R. O., Girard, T. D., and
Ely, E. W. (2007). Post-traumatic stress disorder and post-traumatic stress
symptoms following critical illness in medical intensive care unit patients:
assessing the magnitude of the problem. Crit. Care 11:R27. doi: 10.1186/
cc5707
Jacobsen, P. B., Widows, M. R., Hann, D. M., Andrykowski, M. A., Kronish, L. E.,
and Fields, K. K. (1998). Posttraumatic stress disorder symptoms after bone
marrow transplantation for breast cancer. Psychosom. Med. 60, 366–371. doi:
10.1097/00006842-199805000-00026
Janssens, A. C. J. W., van Doorn, P. A., de Boer, J. B., van der Meché,
F. G. A., Passchier, J., and Hintzen, R. Q. (2003). Impact of recently diagnosed
multiple sclerosis on quality of life, anxiety, depression and distress of
patients and partners. Acta Neurol. Scand. 108, 389–395. doi: 10.1034/j.1600-
0404.2003.00166.x
José Sá, M. (2008). Psychological aspects of multiple sclerosis. Clin. Neurol.
Neurosurg. 110, 868–877. doi: 10.1016/j.clineuro.2007.10.001
Kangas, M. (2013). DSM-5 trauma and stress-related disorders: implications
for screening for cancer-related stress. Front. Psychiatry 4:122. doi:
10.3389/fpsyt.2013.00122
Kangas, M., Henry, J. L., and Bryant, R. A. (2002). Posttraumatic stress
disorder following cancer. Clin. Psychol. Rev. 22, 499–524. doi: 10.1016/S0272-
7358(01)00118-0
Karagkouni, A., Alevizos, M., and Theoharides, T. C. (2013). Effect of stress on
brain inflammation and multiple sclerosis. Autoimmun. Rev. 12, 947–953. doi:
10.1016/j.autrev.2013.02.006
Frontiers in Psychology | www.frontiersin.org 8 April 2016 | Volume 7 | Article 526
fpsyg-07-00526 April 19, 2016 Time: 15:50 # 9
Carletto et al. EMDR vs. Relaxation Therapy for PTSD in MS
Kern, S., and Ziemssen, T. (2008). Brain-immune communication
psychoneuroimmunology of multiple sclerosis. Mult. Scler. 14, 6–21. doi:
10.1177/1352458507079657
Kessler, R. C. (2000). Posttraumatic stress disorder: the burden to the individual
and to society. J. Clin. Psychiatry 61(Suppl. 5), 4–12, discussion 13–14.
Koch, M. W., Patten, S., Berzins, S., Zhornitsky, S., Greenfield, J., Wall, W., et al.
(2015). Depression in multiple sclerosis: along-term longitudinal study. Mult.
Scler. 21, 76–82. doi: 10.1177/1352458514536086
Krupp, L. B., LaRocca, N. G., Muir-Nash, J., and Steinberg, A. D. (1989).
The fatigue severity scale. Application to patients with multiple sclerosis
and systemic lupus erythematosus. Arch. Neurol. 46, 1121–1123. doi:
10.1001/archneur.1989.00520460115022
Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis:
an expanded disability status scale (EDSS). Neurology 33, 1444–1452. doi:
10.1212/WNL.33.11.1444
Kurtzke, J. F. (2015). On the origin of EDSS. Mult. Scler. Relat. Disord. 4, 95–103.
doi: 10.1016/j.msard.2015.02.003
Kwakkenbos, L., Coyne, J. C., and Thombs, B. D. (2014). Prevalence
of posttraumatic stress disorder (PTSD) in women with breast cancer.
J. Psychosom. Res. 76, 485–486. doi: 10.1016/j.jpsychores.2014.03.103
Mitsonis, C. I., Potagas, C., Zervas, I., and Sfagos, K. (2009). The effects of stressful
life events on the course of multiple sclerosis: areview. Int. J. Neurosci. 119,
315–335. doi: 10.1080/00207450802480192
Mohr, D. C. (2007). Stress and multiple sclerosis. J. Neurol. 254(Suppl. 2),
II65–II68. doi: 10.1007/s00415-007-2015-4
Mohr, D. C., Hart, S. L., Julian, L., Cox, D., and Pelletier, D. (2004). Association
between stressful life events and exacerbation in multiple sclerosis: ameta-
analysis. BMJ 328:731. doi: 10.1136/bmj.38041.724421.55
Moore, P., Hirst, C., Harding, K. E., Clarkson, H., Pickersgill, T. P., and Robertson,
N. P. (2012). Multiple sclerosis relapses and depression. J. Psychosom. Res. 73,
272–276. doi: 10.1016/j.jpsychores.2012.08.004
National Collaborating Centre for Mental Health (UK) (2005). Post-Traumatic
Stress Disorder: The Management of PTSD in Adults and Children in Primary
and Secondary Care. Leicester: Gaskell Available at: http://www.ncbi.nlm.nih.g
ov/books/NBK56494/ [accessed June 24, 2015].
Nisipeanu, P., and Korczyn, A. D. (1993). Psychological stress as risk factor
for exacerbations in multiple sclerosis. Neurology 43, 1311–1312. doi:
10.1212/WNL.43.7.1311
Ostacoli, L., Carletto, S., Borghi, M., Cavallo, M., Rocci, E., Zuffranieri, M.,
et al. (2013). Prevalence and significant determinants of post-traumatic stress
disorder in a large sample of patients with multiple sclerosis. J. Clin. Psychol.
Med. Settings 20, 240–246. doi: 10.1007/s10880-012-9323-2
Patti, F., Russo, P., Pappalardo, A., Macchia, F., Civalleri, L., Paolillo, A.,
et al. (2007). Predictors of quality of life among patients with multiple
sclerosis: an Italian cross-sectional study. J. Neurol. Sci. 252, 121–129. doi:
10.1016/j.jns.2006.10.017
Peris, A., Bonizzoli, M., Iozzelli, D., Migliaccio, M. L., Zagli, G., Bacchereti, A., et al.
(2011). Early intra-intensive care unit psychological intervention promotes
recovery from post traumaticstress disorders, anxiety and depression symptoms
in critically ill patients. Crit. Care Lond. Engl. 15, R41. doi: 10.1186/cc10003
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M.,
et al. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the
McDonald criteria. Ann. Neurol. 69, 292–302. doi: 10.1002/ana.22366
Quelhas, R., and Costa, M. (2009). Anxiety, depression, and quality of life
in Parkinson’s disease. J. Neuropsychiatry Clin. Neurosci. 21, 413–419. doi:
10.1176/appi.neuropsych.21.4.413
Schneider, J., Hofmann, A., Rost, C., and Shapiro, F. (2008). EMDR in the
treatment of chronic phantom limb pain. Pain Med. Malden Mass 9, 76–82. doi:
10.1111/j.1526-4637.2007.00299.x
Shapiro, F. (2001). Eye Movement Desensitization and Reprocessing (EMDR): Basic
Principles, Protocols, and Procedures, 2nd Edn. New York, NY: Guilford Press.
Siegert, R. J., and Abernethy, D. A. (2005). Depression in multiple
sclerosis: areview. J. Neurol. Neurosurg. Psychiatry 76, 469–475. doi:
10.1136/jnnp.2004.054635
Silver, S. M., Brooks, A., and Obenchain, J. (1995). Treatment of Vietnam
War veterans with PTSD: acomparison of eye movement desensitization and
reprocessing, biofeedback, and relaxation training. J. Trauma. Stress 8, 337–342.
doi: 10.1002/jts.2490080212
Smith, M. Y., Redd, W. H., Peyser, C., and Vogl, D. (1999). Post-traumatic
stress disorder in cancer: areview. Psychooncology 8, 521–537. doi:
10.1002/(SICI)1099-1611(199911/12)8:6<521::AID-PON423>3.0.CO;2-X
Solari, A., Motta, A., Mendozzi, L., Aridon, P., Bergamaschi, R., Ghezzi, A.,
et al. (2004). Italian version of the Chicago multiscale depression inventory:
translation, adaptation and testing in people with multiple sclerosis. Neurol. Sci.
24, 375–383. doi: 10.1007/s10072-003-0192-1
Taylor, S., Thordarson, D. S., Maxfield, L., Fedoroff, I. C., Lovell, K., and
Ogrodniczuk, J. (2003). Comparative efficacy, speed, and adverse effects of three
PTSD treatments: exposure therapy, EMDR, and relaxation training. J. Consult.
Clin. Psychol. 71, 330–338. doi: 10.1037/0022-006X.71.2.330
Tedstone, J. E., and Tarrier, N. (2003). Posttraumatic stress disorder following
medical illness and treatment. Clin. Psychol. Rev. 23, 409–448. doi:
10.1016/S0272-7358(03)00031-X
Theadom, A., Cropley, M., Smith, H. E., Feigin, V. L., and McPherson, K. (2015).
Mind and body therapy for fibromyalgia. Cochrane Database Syst. Rev. 4,
CD001980. doi: 10.1002/14651858.CD001980.pub3
Tol, W. A., Barbui, C., and van Ommeren, M. (2013). Management of acute stress,
PTSD, and bereavement: WHO recommendations. JAMA 310, 477–478. doi:
10.1001/jama.2013.166723
Tuerk, P. W., Wangelin, B., Rauch, S. A. M., Dismuke, C. E., Yoder, M.,
Myrick, H., et al. (2013). Health service utilization before and after evidence-
based treatment for PTSD. Psychol. Serv. 10, 401–409. doi: 10.1037/a00
30549
Turner, R. J., and Lloyd, D. A. (1995). Lifetime traumas and mental health: the
significance of cumulative adversity. J. Health Soc. Behav. 36, 360–376. doi:
10.2307/2137325
Van Etten, M. L., and Taylor, S. (1998). Comparative efficacy of treatments for post-
traumatic stress disorder: ameta-analysis. Clin. Psychol. Psychother. 5, 126–144.
doi: 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H
van Kessel, K., Moss-Morris, R., Willoughby, E., Chalder, T., Johnson, M. H.,
and Robinson, E. (2008). A randomized controlled trial of cognitive behavior
therapy for multiple sclerosis fatigue. Psychosom. Med. 70, 205–213. doi:
10.1097/PSY.0b013e3181643065
Wallin, M. T., Wilken, J. A., Turner, A. P., Williams, R. M., and Kane, R. (2006).
Depression and multiple sclerosis: review of a lethal combination. J. Rehabil.
Res. Dev. 43, 45–62. doi: 10.1682/JRRD.2004.09.0117
Weathers, F. W., Keane, T. M., and Davidson, J. R. (2001). Clinician-administered
PTSD scale: areview of the first ten years of research. Depress. Anxiety 13,
132–156. doi: 10.1002/da.1029
Weiss, D. S., and Marmar, C. R. (1997). “The impact of event scale-revised,” in
Assessing Psychological Trauma and PTSD, eds J. P. Wilson and T. M. Keane
(New York, NY: Guilford Press), 399–411.
Whalley, B., Thompson, D. R., and Taylor, R. S. (2014). Psychological interventions
for coronary heart disease: cochrane systematic review and meta-analysis. Int.
J. Behav. Med. 21, 109–121. doi: 10.1007/s12529-012-9282-x
Yoo, H. J., Ahn, S. H., Kim, S. B., Kim, W. K., and Han, O. S. (2005). Efficacy
of progressive muscle relaxation training and guided imagery in reducing
chemotherapy side effects in patients with breast cancer and in improving their
quality of life. Support. Care Cancer 13, 826–833. doi: 10.1007/s00520-005-
0806-7
Zigmond, A. S., and Snaith, R. P. (1983). The hospital anxiety and depression scale.
Acta Psychiatr. Scand. 67, 361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x
Zorzon, M., de Masi, R., Nasuelli, D., Ukmar, M., Mucelli, R. P., Cazzato, G.,
et al. (2001). Depression and anxiety in multiple sclerosis. A clinical and
MRI study in 95 subjects. J. Neurol. 248, 416–421. doi: 10.1007/s0041501
70184
Conflict of Interest Statement: AH is the president of EMDR Germany Institute.
The other authors declare that there is no conflict of interest.
Copyright © 2016 Carletto, Borghi, Bertino, Oliva, Cavallo, Hofmann, Zennaro,
Malucchi and Ostacoli. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Psychology | www.frontiersin.org 9 April 2016 | Volume 7 | Article 526
